Allergie Zentrum
© KUK

Publikationen


2024

Hereditary alpha tryptasemia: elevated tryptase, female sex, thyroid disorders, and anaphylaxis

Puxkandl V, Aigner S, Hoetzenecker W, Altrichter S
Front Allergy. 2024 Nov 12;5:1461359. doi: 10.3389/falgy.2024.1461359

Validation of the Cholinergic Urticaria Activity Score (CholUAS)

Schnarkowski P, Salameh P, Grekowitz E, Terhorst-Molawi D, Maurer M, Weller K, Altrichter S
J Allergy Clin Immunol Pract. 2025 Jan;13(1):213-219.e3. doi: 10.1016/j.jaip.2024.10.011

Skin reaction patterns in cholinergic urticaria

Shurmelova I, Baldyga A, Grekowitz E, Kimeswenger S, Hoetzenecker W, Maurer M, Altrichter S
Allergol Int. 2025 Jan;74(1):115-125. doi: 10.1016/j.alit.2024.07.008

Inducible Urticaria

Ritzel D, Altrichter S
Immunol Allergy Clin North Am. 2024 Aug;44(3):439-452. doi: 10.1016/j.iac.2024.03.003

Basophil and eosinophil recruitment to skin lesions is linked to features of autoimmune chronic spontaneous urticaria including basopenia

Jiao Q, Lohse K, Rauber-Ellinghaus MM, Kolkhir P, Frischbutter S, Scheffel J, Xiang YK, Maurer M, Altrichter S
J Eur Acad Dermatol Venereol. 2025 Feb;39(2):e155-e157. doi: 10.1111/jdv.20204

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

Kogseder N, Puxkandl V, Hoetzenecker W, Altrichter S
Front Immunol. 2024 May 17;15:1324987. doi: 10.3389/fimmu.2024.1324987

Altered Sweat Composition Due to Changes in Tight Junction Expression of Sweat Glands in Cholinergic Urticaria Patients

Daci D, Altrichter S, Grillet FM, Dib S, Mouna A, Suresh Kumar S, Terhorst-Molawi D, Maurer M, Günzel D, Scheffel J
Int J Mol Sci. 2024 Apr 25;25(9):4658. doi: 10.3390/ijms25094658

The European Network for IgE-Mediated Autoimmunity and Autoallergy (ENIGMA) initiative

Kolkhir P, Altrichter S, Badloe FMS, Belasri H, Charles N, De Vriese S, Gutermuth J, Huygen L, Kocatürk E, Kortekaas Krohn I, Muñoz M, Moñino-Romero S, Reber LL, Scheffel J, Steinert C, Xiang YK, Maurer M
Nat Med. 2024 Apr;30(4):920-922. doi: 10.1038/s41591-024-02819-9

ARROYO Study Investigators. Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial

Altrichter S, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ
Br J Dermatol. 2024 Jul 16;191(2):187-199. doi: 10.1093/bjd/ljae067

 

2023

Hereditäres Angioödem durch C1-Inhibitor-Mangel, eine nationale Versorgungsleitlinie [Hereditary angioedema due to C1-inhibitor deficiency, a national disease management programme]

Aberer W, Altrichter S, Cerpes U, Hawranek T, Schöffl C, Kinaciyan T
Wien Klin Wochenschr. 2023 Nov;135(Suppl 8):785-798. German. doi: 10.1007/s00508-023-02298-x. Epub 2023 Dec 8

One in five patients with chronic spontaneous urticaria has IgE to tissue transglutaminase 2

Su H, Kolkhir P, Scheffel J, Xiang YK, Yao X, Maurer M, Altrichter S
Allergy 2023 Sep;78(9):2537-2539. doi: 10.1111/all.15734

Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria

Moñino-Romero S, Kolkhir P, Ohanyan T, Szépfalusi Z, Weller K, Metz M, Scheffel J, Maurer M, Altrichter S
J Eur Acad Dermatol Venereol. 2023 Aug 29. doi: 10.1111/jdv.19485

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria

Moñino-Romero S, Kolkhir P, Szépfalusi Z, Schoepke N, Metz M, Asero R, Ferrer M, Gimenez-Arnau A, Grattan CEH, Jakob T, Konstantinou GN, Raap U, Staubach P, Zhang K, Bindslev-Jensen C, Daschner A, Kinaciyan T, Makris M, Marrouche N, Schmid-Grendelmeier P, Sussman G, Toubi E, Maurer M, Altrichter S
Clin Transl Allergy. 2023 Jul;13(7):e12272. doi: 10.1002/clt2.12272

S3 Guideline Urticaria. Part 2: Treatment of urticaria - German-language adaptation of the international S3 guideline

Zuberbier T, Altrichter S, Bauer S, Brehler R, Brockow K, Dressler C, Fluhr J, Gaskins M, Hamelmann E, Kühne K, Merk H, Mülleneisen NK, Nast A, Olze H, Ott H, Pleimes M, Ruëff F, Staubach-Renz P, Wedi B, Maurer M
J Dtsch Dermatol Ges. 2023 Feb;21(2):202-215. doi: 10.1111/ddg.14932

S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria - German-language adaptation of the international S3 Guideline

Zuberbier T, Altrichter S, Bauer S, Brehler R, Brockow K, Dressler C, Fluhr J, Gaskins M, Hamelmann E, Kühne K, Merk H, Mülleneisen NK, Nast A, Olze H, Ott H, Pleimes M, Ruëff F, Staubach-Renz P, Wedi B, Maurer M
J Dtsch Dermatol Ges. 2023 Jan;21(1):81-93. doi: 10.1111/ddg.14906

Therapy resistant urticaria as a long-term symptom of an incomplete Schnitzler syndrome

Puxkandl V, Currie A, Hoetzenecker W, Altrichter S
Allergy Asthma Clin Immunol. 2023 Jul 26;19(1):64. doi: 10.1186/s13223-023-00819-x

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupiluma

Puxkandl V, Hoetzenecker W, Altrichter S
Allergol Select. 2023 Jan 3;7:17-19. doi: 10.5414/ALX02382E

Soluble IgE-binding factors in the serum of food-allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor

Steinert C, Moñino-Romero S, Butze M, Scheffel J, Dölle-Bierke S, Dobbertin-Welsch J, Beyer K, Maurer M, Altrichter S
Clin Transl Allergy. 2023 Feb;13(2):e12222. doi: 10.1002/clt2.12222

Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not ViceVersa

Xiang YK, Kolkhir P, Scheffel J, Sauer M, Vera C, Frischbutter S, Krause K, Siebenhaar F, Metz M, Maurer M, Altrichter S
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2417-2425.e1. doi: 10.1016/j.jaip.2023.02.006

 

2022

Guidelines for diagnosis, prevention and treatment of hand eczema

Thyssen J, Schuttelaar M, Alfonso J, Andersen K, Angelova-Fischer I et al.
Contact Dermatitis 2022;86:357-378. doi: 10.1111/cod.14035

An interdisciplinary approach to characterize peanut-allergic patients-First data from the FOOD@ consortium

Worm M, Alexiou A, Höfer V, Birkner T, Jeanrenaud ACSN, Fauchère F, Pazur K, Steinert C, Arnau-Soler A, Banerjee P, Diefenbach A, Dobbertin-Welsch J, Dölle-Bierke S, Francuzik W, Ghauri A, Heller S, Kalb B, Löber U, Marenholz I, Markó L, Scheffel J, Potapenko O, Roll S, Lau S, Lee YA, Braun J, Thiel A, Babina M, Altrichter S, Forslund SK, Beyer K
Clin Transl Allergy. 2022 Oct 5;12(10):e12197. doi: 10.1002/clt2.12197

Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands

Wang Y, Scheffel J, Vera CA, Liu W, Günzel D, Terhorst-Molawi D, Maurer M, Altrichter S
Front Immunol. 2022 Jul 29;13:955161. doi: 10.3389/fimmu.2022.955161

Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience

Puxkandl V, Bangerl T, Hanfstingl K, Guenova E, Hoetzenecker W, Altrichter S
World Allergy Organ J. 2022 Jun;15(6):100654. doi: 10.1016/j.waojou.2022.100654

Development of the Cold Urticaria Activity Score

Ahsan DM, Altrichter S, Gutsche A, Bernstein JA, Altunergil T, Brockstaedt M, Maurer M, Weller K, Terhorst-Molawi D
Allergy. 2022 Aug;77(8):2509-2519. doi: 10.1111/all.15310

An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria

Altrichter S, Staubach P, Pasha M, Singh B, Chang AT, Bernstein JA, Rasmussen HS, Siebenhaar F, Maurer M
J Allergy Clin Immunol. 2022 May;149(5):1683-1690.e7. doi: 10.1016/j.jaci.2021.12.772